Neural Regeneration Research ›› 2012, Vol. 7 ›› Issue (18): 1406-1411.

Previous Articles     Next Articles

The 9LLUC/Wistar rat glioma model is not suitable for immunotherapy

1 Department of Medicine, the 263 Hospital, Beijing 101149, China
2 Department of Neurology, South West Hospital, the Third Military Medical University of Chinese PLA, Chongqing 400038, China
3 Department of Stem Cell and Regenerative Medicine, Beijing Institute of Transfusion Medicine, Beijing 100850, China
4 Department of Neurosurgery, the 263 Hospital, Beijing 101149, China   

  • Received:2012-01-30 Revised:2012-03-22 Online:2012-06-25 Published:2012-06-25
  • Contact: Xuetao Pei, Ph.D., Professor, Department of Stem Cell and Regenerative Medicine, Beijing Institute of Transfusion Medicine, Beijing 100850, China peixt@nic.bmi.ac.cn
  • About author:Liping Yang☆, M.D., Associate chief physician, Department of Medicine, the 263 Hospital, Beijing 101149, China; Department of Neurology, South West Hospital, the Third Military Medical University of Chinese PLA, Chongqing 400038, China

Key words: 9L cells, glioma, F344 rats, Wistar rats, animal model, bioluminescence imaging, immune response, neural regeneration